Patients Clinicians About Investor Center FIND A DOCTOR Investor Relations The Leader in Brachytherapy Isoray advances innovative radiotherapeutic technologies that focus on the patient. Isoray Announces First Quarter Fiscal 2022 Financial Results November 10, 2021 READ MORE Latest Results Isoray Reschedules Fourth Quarter and Fiscal Year End 2021 Financial Results Conference Call to September 22, 2021 Due to Conference Provider Technical Issues Isoray Announces Fourth Quarter and Full-Year Fiscal Year End 2021 Financial Results Isoray To Announce Fourth Quarter and Fiscal Year End 2021 Financial Results on September 21, 2021 Isoray Announces Second Quarter Fiscal 2021 Financial Results Isoray Announces First Quarter Fiscal 2021 Financial Results VIEW ALL RELEASES Investor Resources Press Releases SEC Filings Presentations Governance Nominations and Corporate Governance Committee Compensation Committee Charter Code of Ethics for Senior Leadership Code of Conduct and Ethics Audit Committee Research Analyst Coverage Northland Capital Markets Tim Chiang Lake Street Capital Markets, LLC Frank Takkinen Oppenheimer & Co. Suraj Kalia, CFA Dawson James Securities Inc. Jason Kolbert Ascendiant Capital Markets Edward Woo Do you have questions? We’ll put you in touch with someone to answer any of your investor related questions. Investor Relations: Mark Levin Global IR Group mark@globalirgroup.com CONTACT US Our Management Team Learn more about our experienced management team who are focused on growth. LEARN MORE Investor News Alerts Use the button below to email us and receive the latest investor focused news from Isoray. CLICK TO EMAIL Proven • Personalized • Precise Patients & Families Cesium Blu Prostate Cancer Treatment Areas Together Community Doctors & Clinicians Cesium Blu The Data Contact Us Our Products Our company About Us Careers Contact Us Connect with us: Copyright © 2021 Isoray Inc. Terms of Use Privacy Policy Disclosure: The physicians featured on this website may have prior or current relationships with Isoray. These relationships may include, for example: membership on Isoray’s Advisory Board; participation as a clinical investigator in research conducted on Isoray products; provision of consultation or training services; or engagement as a prospective partner in the development of new products. Many of these physicians have received or continue to receive compensation from Isoray in one form or another. The principal nature of a specific physician’s relationship is disclosed on this website adjacent to language featuring that physician. Which of these best describes you? I'm a patient or family member living with cancer. I'm a clinician or doctor. I'm an investor. Other Powered byRightMessage ✕